Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein

Journal of General Virology

Volumn 79, Issue 4, 1998, Pages 767-777

  Schaefer, Stephan ^a   Seifer, Maria ^b,c   Grimmsmann, Thomas ^b   Fink, Ludger ^a   Wenderhold, Sabine ^a   Höhne, Martin W ^a   Gerlich, Wolfram H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS MESSENGER RNA;

ARTICLE; CELL LINE; CELL TRANSFORMATION; HEPATITIS B VIRUS; LIVER CELL; LIVER CELL CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; TRANSACTIVATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0031949796     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-4-767     Document Type: Article

References (46)

1. Appel, K., Wagner, P., Boldyreff, B., Issinger, O. & Montenarh, M. (1995). Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta sub-unit of protein kinase CK2. Oncogene 11, 1971-1978.
2. Balsano, C., Billet, O., Bennoun, M., Cavard, C., Zider, A., Grimber, G., Natoli, G., Briand, P. & Levrero, M. (1994). Hepatitis B virus X gene product acts as a transactivator in vivo. Journal of Hepatology 21, 103-109.
3. Beasley, R. P. & Hwang, L. Y. (1984). Hepatocellular carcinoma and hepatitis B virus. Seminars in Liver Disease 4, 113-121.
4. Chirillo, P., Pagano, S., Natoli, G., Puri, P. L., Burgio, V. L., Balsano, C. & Levrero, M. (1997). The hepatitis B virus X gene induces p53-mediated programmed cell death. Proceedings of the National Academy of Sciences, USA 94, 8162-8167.
5. Doria, M., Klein, N., Lucito, R. & Schneider, R. J. (1995). The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO Journal 14, 4747-4757.
6. Feitelson, M. A., Zhu, M., Duan, L. X. & London, W. T. (1993). Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8, 1109-1117.
7. Gorman, C. (1985). High efficiency gene transfer into mammalian cells. In DNA Cloning - A Practical Approach, pp. 143-190. Edited by D. Glover. Washington & Oxford: IRL Press.
8. Henkler, F. & Koshy, R. (1996). Multiple functions of the hepatitis B virus X protein. Viral Hepatitis Reviews 2, 143-159.
9. Hildt, E., Hofschneider, P. H. & Urban, S. (1996). The role of hepatitis B virus (HBV) in the development of hepatocellular carcinoma. Seminars in Virology 7, 333-347.
10. Hinds, P. W. & Weinberg, R. A. (1994). Tumor suppressor genes. Current Opinion in Genetics and Development 4, 135-141.
11. Hoffmann, B., Piasecki, A. & Paul, D. (1989). Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture. Journal of Cell Physiology 139, 654-662.
12. Höhne, M., Piasecki, A., Ummelmann, E. & Paul, D. (1987). Transformation of differentiated neonatal rat hepatocytes in primary culture by polyoma virus early region sequences. Oncogene 1, 337-345.
13. Höhne, M., Schaefer, S., Seifer, M., Feitelson, M. A., Paul, D. & Gerlich, W. H. (1990). Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO Journal 9, 1137-1145.
14. Höhne, M. W., Zieroth, S., Veser, U., Kahl, G. F. & Schwarz, L. R. (1993). Carcinogen-induced diploid hepatocytes: sensitive target cells for transformation by mutated c-Ha-ras oncogene. Molecular Carcinogenesis 7, 180-189.
15. Kim, C. M., Koike, K., Saito, I., Miyamura, T. & Jay, G. (1991). HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351, 317-320.
16. Klein, R., Schröder, C. H. & Zentgraf, H. (1991). Expression of the X protein of hepatitis B virus in insect cells using recombinant baculoviruses. Virus Genes 5, 157-174.
17. Kunkel, T. A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proceedings of the National Academy of Sciences, USA 82, 488-492.
18. Lane, D. P., Stephen, C. W., Midgley, C. A., Sparks, A., Hupp, T. R., Daniels, D. A., Greaves, R., Reid, A., Vojtesek, B. & Picksley, S. M. (1996). Epitope analysis of the murine p53 tumour suppressor protein. Oncogene 12, 2461-2466.
19. Lee, T. H., Finegold, M. J., Shen, R. F., DeMayo, J. L., Woo, S. L. & Butel, J. S. (1990). Hepatitis B virus transactivator X protein is not tumorigenic in transgenic mice. Journal of Virology 64, 5939-5947.
20. Luber, B., Arnold, N., Stürzl, M., Höhne, M., Schirmacher, P., Lauer, U., Wienberg, J., Hofschneider, P. H. & Kekulé, A. S. (1996). Hepatoma-derived integrated HBV-DNA causes multi-stage transformation in vitro. Oncogene 12, 1597-1608.
21. Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F. & Deppert, W. (1995). Negative feedback regulation of wild-type p53 biosynthesis. EMBO Journal 14, 4442-4449.
22. Müller, E., Boldyreff, B. & Scheidtmann, K. H. (1993). Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells. Oncogene 8, 2193-2205.
23. Myers, R. M., Larin, Z. & Maniatis, T. (1985). Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes. Science 230, 1242-1246.
24. Oguey, D., Dumenco, L. L., Pierce, R. H. & Fausto, N. (1996). Analysis of the tumorigenicity of the X gene of HBV in a non-transformed hepatocyte cell line and the effects of cotransfection with murine p53 mutant equivalent to human codon 249. Hepatology 24, 1024-1033.
25. Paul, D., Höhne, M., Pinkert, C., Piasecki, A., Ummelmann, E. & Brinster, R. L. (1988). Immortalized differentiated hepatocyte lines derived from transgenic mice harboring SV40 T-antigen genes. Experimental Cell Research 175, 354-362.
26. Perfumo, S., Amicone, L., Colloca, S., Giorgio, M., Pozzi, L. & Tripodi, M. (1992). Recognition efficiency of the hepatitis B virus poly-adenylation signals is tissue specific in transgenic mice. Journal of Virology 66, 6819-6823.
27. Robinson, W. S. (1994). Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Annual Review of Medicine 45, 297-323.
28. Rogler, C. E. & Chisari, F. V. (1992). Cellular and molecular mechanisms of hepatocarcinogenesis. Seminars in Liver Disease 12, 265-278.
29. Schaefer, S. & Gerlich, W. H. (1995). In vitro transformation by hepatitis B virus DNA. Intervirology 38, 143-154.
30. Scheidtmann, K. H. (1989). SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53. Current Topics in Microbiology and Immunology 144, 85-88.
31. Schek, N., Bartenschlager, R., Kuhn, C. & Schaller, H. (1991). Phosphorylation of hepatitis B virus X-protein expressed in HepG2 cells from a recombinant vaccinia virus. Oncogene 6, 1735-1744.
32. Schmieg, F. I. & Simmons, D. T. (1984). Intracellular location and kinetics of complex formation between simian virus 40 T antigen and cellular protein p53. Journal of Virology 52, 350-355.
33. Seifer, M. & Gerlich, W. H. (1992). Increased growth of permanent mouse fibroblasts in soft agar after transfection with hepatitis B virus DNA. Archives of Virology 126, 119-128.
34. Seifer, M., Heermann, K. H. & Gerlich, W. H. (1990a). Expression pattern of the hepatitis B virus genome in transfected mouse fibroblasts. Virology 179, 287-299.
35. Seifer, M., Heermann, K. H. & Gerlich, W. H. (1990b). Replication of hepatitis B virus in transfected nonhepatic cells. Virology 179, 300-311.
36. Seifer, M., Höhne, M., Schaefer, S. & Gerlich, W. H. (1991). In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. Journal of Hepatology 13, S61-S65.
37. Shin, S. I., Freedman, V. H., Risser, R. & Pollack, R. (1975). Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proceedings of the National Academy of Sciences, USA 72, 4435-4439.
38. Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M. & Koike, K. (1989). The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Japanese Journal of Cancer Research 80, 617-621.
39. Su, F. & Schneider, R. J. (1997). Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proceedings of the National Academy of Sciences, USA 94, 8744-8749.
40. Takada, S., Kaneniwa, N., Tsuchida, N. & Koike, K. (1997). Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells. Oncogene 15, 1895-1901.
41. Treinin, M. & Laub, O. (1987). Identification of a promoter element located upstream from the hepatitis B virus X gene. Molecular and Cellular Biology 7, 545-548.
42. Truant, R., Antunovic, J., Greenblatt, J., Prives, C. & Cromlish, J. A. (1995). Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. Journal of Virology 69, 1851-3859.
43. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A. & Jay, G. (1995). Functional inactivation but not structural nutation of p53 causes liver cancer. Nature Genetics 9, 41-47.
44. Wang, X. W., Forrester, K., Yen, H., Feitelson, M. A., Gu, J. R. & Harris, C. C. (1994). Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proceedings of the National Academy of Sciences, USA 91, 2230-2234.
45. Wang, X. W., Gibson, M. K., Vermeulen, W., Yen, H., Forrester, K., Sturzbecher, H. W., Hoeijmakers, J. H. & Harris, C. C. (1995). Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Research 55, 6012-6016.
46. Zahm, P., Hofschneider, P. H. & Koshy, R. (1988). The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene 3, 169-177.